[Blood coagulation state in destructive pulmonary tuberculosis patients under different methods of chemotherapy]. 1981

V Ia Sagalovich, and R E Beresneva, and V B Ivanova

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

V Ia Sagalovich, and R E Beresneva, and V B Ivanova
January 1980, Vestnik rentgenologii i radiologii,
V Ia Sagalovich, and R E Beresneva, and V B Ivanova
December 1978, Problemy tuberkuleza,
V Ia Sagalovich, and R E Beresneva, and V B Ivanova
January 1987, Problemy tuberkuleza,
V Ia Sagalovich, and R E Beresneva, and V B Ivanova
July 1974, AMB : revista da Associacao Medica Brasileira,
V Ia Sagalovich, and R E Beresneva, and V B Ivanova
October 1981, Problemy tuberkuleza,
V Ia Sagalovich, and R E Beresneva, and V B Ivanova
February 1981, Vrachebnoe delo,
V Ia Sagalovich, and R E Beresneva, and V B Ivanova
October 1968, Vrachebnoe delo,
V Ia Sagalovich, and R E Beresneva, and V B Ivanova
January 1987, Problemy tuberkuleza,
V Ia Sagalovich, and R E Beresneva, and V B Ivanova
February 1979, Problemy tuberkuleza,
V Ia Sagalovich, and R E Beresneva, and V B Ivanova
January 1971, Problemy tuberkuleza,
Copied contents to your clipboard!